Skip to main content
. 2021 May 4;67(6):2577–2583. doi: 10.1007/s10620-021-07007-0

Table 2.

Relative risks’ main outcomes in patients with MEL or LI compared to control

Outcome Mildly elevated liver enzymes versus control Liver injury versus control
Relative risk (95% CI) aP value Relative risk (95% CI) aP value
60-day mortality 2.16 (1.59–2.95)  < 0.0001 4.26 (3.12–5.81)  < 0.0001
ICU admission 2.5 (1.8–3.4)  < 0.0001 5.52 (4.07–7.49)  < 0.0001
Intubation 3.76 (2.36–5.99)  < 0.0001 11.01 (6.97–17.34)  < 0.0001
30-day readmission 1.25 (0.86–1.82) 0.2415 1.81 (1.17–2.80) 0.0076

ICU, intensive care unit; LI, liver injury; MEL, mild elevation in liver enzymes; RR, relative risk

aP values reported using Chi-square test